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        To avoid chronic cell activation and infl  amma-
tion against nonpathogenic antigens through skin, 
ingestion, and inhalation, the immune system has 
developed effi   cient peripheral tolerance mecha-
nisms. Allergic diseases are caused by an aberrant 
immune response mediated through a key eff  ec-
tor cell, the Th2 cell, and an associated cytokine 
pattern including IL-4, IL-5, and IL-13 (  1  ). Con-
sequently, the most pronounced fi  ndings  with 
potential relevance to allergy therapy are related 
directly to the control of these Th2 immune ef-
fectors. There is strong evidence that peripheral 
T cell regulation plays a crucial role in the control 
of harmful T cell responses. Since the early 1970s, 
many types of suppressor mechanisms have been 
demonstrated, and the biology of T reg cells has 
been the subject of intensive investigation (  2  –  6  ). 
  Subsets of   T reg cells with distinct phenotypes 
and mechanisms of action include the naturally 
occurring, thymic-selected CD4  +  CD25  +  FoxP3  +   
T reg cells, and the inducible type 1 T regulatory 
(Tr1) cells (  7  –  12  ). A great deal of uncertainty 
remains about diff  erentiation factors, antigen 
specifi  city, and mechanisms of action of T reg 
cells. Several types of adaptive T reg cells have 
been described with a unique mechanism of 
action that varies depending on the experimental 
model. T reg cells act as suppressor T cells, which 
down-regulate eff  ector cells and APCs in vitro 
and in infl  ammation models such as various 
chronic infections, organ transplantation, allergy, 
and autoimmunity (  7  –  12  ). Although molecular 
mechanisms of T reg cell generation remain to 
be elucidated, some existing therapies for allergic 
diseases, such as treatment with glucocorticoids 
and     -2 agonists, might function to promote the 
numbers and function of IL-10  –  secreting Tr1-
like cells (  13, 14  ). 
  Studies on the immune response to allergens 
provide well-defi  ned models for understanding 
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  High dose bee venom exposure in beekeepers by natural bee stings represents a model to 
understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous 
exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished 
T cell  –  related cutaneous late-phase swelling to bee stings in parallel with suppressed 
allergen-specifi  c T cell proliferation and T helper type 1 (Th1) and Th2 cytokine secretion. 
After multiple bee stings, venom antigen  –  specifi  c Th1 and Th2 cells show a switch toward 
interleukin (IL) 10  –  secreting type 1 T regulatory (Tr1) cells. T cell regulation continues as 
long as antigen exposure persists and returns to initial levels within 2 to 3 mo after bee 
stings. Histamine receptor 2 up-regulated on specifi  c Th2 cells displays a dual effect by 
directly suppressing allergen-stimulated T cells and increasing IL-10 production. In addi-
tion, cytotoxic T lymphocyte  –  associated antigen 4 and programmed death 1 play roles in 
allergen-specifi  c T cell suppression. In contrast to its role in mucosal allergen tolerance, 
transforming growth factor      does not seem to be an essential player in skin-related 
allergen tolerance. Thus, rapid switch and expansion of IL-10  –  producing Tr1 cells and the 
use of multiple suppressive factors represent essential mechanisms in immune tolerance to 
a high dose of allergens in nonallergic individuals. 
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sponses in response to bee stings. They do not wear protec-
tive masks or gloves and receive numerous bee stings as a 
result of their occupation. The beekeeping season begins in 
the last week of April and continues until October (  Fig. 1 A  ).   
During the fi  rst week of the season, beekeepers received an 
average of 13 bee stings, which resulted in the development 
of cutaneous late-phase responses (  Fig. 1 B  ), but did not 
induce fever, swelling of the draining lymph nodes, or sple-
nomegaly. Exposure to bee venom antigens induced a signif-
icantly milder cutaneous late-phase swelling response after 
the fi  rst week, which continued throughout the season. At 
the beginning of the next beekeeping season, skin reactions 
to bee stings returned to the levels seen during the fi  rst week 
of the previous season and declined thereafter (  Fig. 1 B  ). This 
pattern repeated for three consecutive years. The inset shows 
the initial size of the skin lesions in 9 beekeepers, which de-
creased signifi  cantly after 7 d (  Fig. 1 B  ). T cells play a major 
role in cutaneous late-phase responses, and lesion size corre-
lates with infi  ltrating T cell numbers (  21  ). Peripheral blood 
T cells in the beekeepers proliferated in response to the 
major bee venom allergen PLA during the fi  rst 4 mo of the 
year. Shortly after the beginning of the beekeeping season, 
PLA-specifi  c T cell proliferation declined dramatically and 
then returned to initial levels approximately 2 mo after the 
end of the beekeeping season (  Fig. 1 C  ). The same T cell 
response profi  le was observed every year, demonstrating 
a short-lived peripheral T cell unresponsiveness. This un-
responsiveness appeared to be antigen specifi  c, as T cell pro-
liferation in response to purifi  ed protein derivative (PPD) and 
tetanus toxoid (TT) antigens did not change in response to 
bee stings (  Fig. 1 D  ). 
  Increased IL-10  –  secreting Tr1-like T cell responses 
immediately after high dose venom exposure 
  To investigate the mechanism underlying the T cell unre-
sponsiveness, PLA-specifi  c T cells were characterized before 
and after multiple bee stings. The frequency of PLA-specifi  c 
T cells was determined according to their IL-4, IFN-    , and 
IL-10 secretion profi  les before and 7 d after the beginning of 
the beekeeping season. The overall number of PLA-specifi  c 
T cells showed a slight increase from 12.4 to 14.8 in 10,000 
CD4  +   T cells. However, the number of IL-10  –  producing 
T cells increased dramatically after 7 d, from 5.52   ±   1.93 
to 11.87   ±   3.12 in 10,000 CD4  +  T cells (  Fig. 2 A  ).   The num-
ber of IL-4  –  producing CD4  +   T cells, in contrast, decreased 
from 1.23   ±   0.32 to 0.43   ±   0.17, and IFN-      –  secreting T 
cells decreased from 5.66   ±   0.92 to 2.49   ±   0.76 after the 
fi  rst 7 d of the season. Similar changes were also seen in the 
frequency of IL-10, IFN-      –  , and IL-4  –  secreting T cells by 
ELISPOT (  Fig. 2 B  ). Although the ELISPOT data were more 
variable, no statistically signifi  cant diff  erences in cytokine-pro-
ducing T cell numbers were noted between the two techniques. 
The shift in the frequency of cytokine-secreting T cells was 
consistent with changes in the overall cytokine profi  le of 
PLA-specifi  c T cells after multiple bee stings (  Fig. 2, C and D  ). 
Outside of beekeeping season (from December to February), 
the regulation and circumvention of antigen-specifi  c T cell 
responses. The symptoms of IgE-mediated allergy  —  rhinitis, 
conjunctivitis, and asthma  —  can be ameliorated by the tempo-
rary suppression of mediators and immune cells (e.g., therapies 
such as antihistamines and corticosteroids) (  15, 16  ). However, 
the only long-term solution for the treatment of allergy is 
allergen  –  specifi  c immunotherapy (SIT) by the administration 
of high doses of allergen or allergen peptides that specifi  cally 
target T cells over a long period of time (  16  ). Successful venom 
and aeroallergen immunotherapy is associated with the induc-
tion of peripheral tolerance in T cells by the generation of T reg 
cells that secrete suppressive cytokines, IL-10, and TGF-    , sug-
gesting that generation of Tr1 cells may play a role in healthy 
immune responses (  12, 17, 18  ). 
  Histamine and four diff  erent histamine receptors (HRs) 
constitute a multifaceted system with distinct functions of 
  receptor types because of their diff  erential expression, which 
changes according to the stage of cell diff  erentiation and in-
fl  uences of the microenvironment (  19  ). It has been demon-
strated that distinct patterns of HR expression on Th1 and 
Th2 cells determine reciprocal T cell responses after histamine 
stimulation (  15  ). Th1 cells show predominant but not exclu-
sive expression of HR1, whereas Th2 cells show increased ex-
pression of HR2. Histamine enhances Th1-type responses by 
triggering the HR1. In contrast, the HR2 seems to be a potent 
suppressor of T cell functions (  15  ). The expression and role 
of these receptors in CD4  +   T cells of healthy individuals dur-
ing high dose allergen exposure was given particular focus in 
the present study. 
  Investigation of allergen-specifi  c peripheral T cell response 
in nonallergic beekeepers in and out of the beekeeping sea-
son has enabled us to study essential questions in peripheral 
T cell tolerance. One bee sting contains     50   μ  g of protein con-
sisting of several diff  erent antigens that are directly inoculated 
into the skin. The major allergen phospholipase A  2   (PLA) is 
responsible for allergic reactions in almost all of the sensitized 
individuals and comprises     10  –  20% of bee venom  ’  s protein 
content (  20  ). In the present study, we used several direct meth-
ods to analyze human-specifi  c T cell response in beekeepers, 
who were followed for several consecutive years during and 
outside beekeeping season. This represents a relevant model 
to investigate mechanisms of immune tolerance to high dose 
allergen exposure in humans. We demonstrated that high 
dose allergen tolerance is associated with clonal expansion of 
specifi  c IL-10  –  secreting Tr1 cells, which may switch in vivo 
from existing Th1- and Th2-like allergen-specifi  c cells. In-
creased expression of HR2 on Th2 cells a few days after allergen 
exposure plays a suppressor role in these cells and increases 
IL-10 production. 
    RESULTS   
  High dose allergen exposure via skin decreases cutaneous 
late-phase responses and induces unresponsiveness 
in allergen-specifi  c T cells 
  The beekeepers that were investigated in this study are not 
allergic to bee venom and develop cutaneous late-phase re-JEM VOL. 205, November 24, 2008 
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Der p 1  –  specifi  c IL-10  –  secreting T cells had no eff  ect on PLA-
stimulated T cell proliferation (  Fig. 2 E  , columns 8  –  11), dem-
onstrating that the induction of T cell unresponsiveness was 
allergen specifi  c. 
  In vivo switch of allergen-specifi  c Th2 and Th1 cells 
toward IL-10  –  secreting Tr1 cells 
  The shift in the cytokine profi  le to a predominantly IL-10  –
  producing population 7 d after the onset of bee stings in vivo 
suggested that there was an increase in the number of aller-
gen-specifi  c Tr1 cells. We next asked whether this switch 
occurs as a result of the clonal expansion of existing antigen-
specifi  c memory Th1 and Th2 cells or whether new Tr1 cells 
were generated from the naive T cell pool. This was analyzed in 
two ways. First, we determined, the clonality of IL-4  –  , IL-10  –  , 
and IFN-      –  secreting T cells by combining PCR analysis to 
assess clonal TCR      chain gene rearrangements with hetero-
duplex analysis to diff  erentiate clonal and nonclonal PCR prod-
ucts. Using primers spanning diff  erent parts of TCR variable      
(TCRV    ) chain, junction, and diversity regions (Fig. S1,   available 
at http://www.jem.org/cgi/content/full/jem.20080193/DC1), 
PLA-specifi  c T cells predominantly produced IL-10 and 
IFN-    , as well as lower levels of IL-4 and IL-13. 7 d after the 
onset of the season (and after receiving multiple bee stings), 
PLA-stimulated T cells produced mostly IL-10 and very little 
IFN-    , IL-4, or IL-13 (  Fig. 2 C  ). 
  We next tested whether the shift in cytokine-producing 
cells aff  ected T cell proliferation. PLA-specifi  c IFN-      –  , IL-4  –  , 
and IL-10  –  secreting T cells were purifi  ed and added back to 
cultures of autologous PBMCs, such that their frequency was 
    10 times higher than their initial levels in PBMCs (  Fig. 2 E  ). 
IL-10  –  secreting T cells specifi  c for the unrelated allergens Bet 
v 1 and Der p 1 were purifi  ed from the same beekeepers. Pro-
liferation of PBMCs in response to PLA, which was abolished 
after the onset of bee stings, was restored by adding PLA-spe-
cifi  c IFN-      –   or IL-4  –  producing cells to the cultures (  Fig. 2 E  , 
columns 1  –  4). If IL-10  –  secreting T cells were added alone or 
with IFN-      –   or IL-4  –  producing cells, proliferation was not 
restored (  Fig. 2 E  , columns 5  –  7). In this case, PLA-specifi  c 
IL-10  –  secreting T cells signifi  cantly suppressed the prolifera-
tion of PLA-specifi  c IL-4  –   and IFN-      –  secreting T cells. The 
addition of IL-10  –  producing cells specifi  c for Bet v 1  –   or 
    Figure 1.         Decreased antigen-specifi  c T cell response and cutaneous late-phase response after natural high dose antigen exposure.   (A) The num-
ber of bee stings per month in nine beekeepers is. (B) Decreased cutaneous late-phase response after bee stings returns to initial levels upon no exposure. 
Five beekeepers who showed large cutaneous late-phase responses at the beginning of each beekeeping season were followed for 3 yr  (2003 – 2005).  The 
lesion size was graded as follows: 2,   >  3 cm; 1, 0  –  3 cm; and 0, no swelling (dark gray bar, 2003; gray bar, 2004; open bar, 2005). The scale of 10 demonstrates 
that in all of the fi  ve beekeepers, the skin lesion size was   >  3 cm at the beginning of each season. (inset) The direct measurement of cutaneous late-phase 
response lesion size in nine beekeepers in 2007 before and 7 d after bee stings. (C) PLA-induced [  3  H]thymidine incorporation in PBMCs after 5 d in two bee-
keepers followed for three years (gray circles and triangles) and two beekeepers followed for two consecutive years (open squares and circles; 67 peripheral 
blood samples). (inset) PLA-induced [  3  H]thymidine incorporation signifi  cantly decreased in all 29 experiments before and 7 d after bee stings between 2001 
and 2007. (D) T cell proliferation against control antigens (PPD and TT) did not show any change in three beekeepers throughout the year. *, P   <   0.001.     2890 T REGULATORY 1 CELLS IN HIGH DOSE ALLERGEN TOLERANCE   | Meiler et al. 
we found that purifi  ed PLA-specifi  c IFN-      –  , IL-4  –  , and 
IL-10  –  secreting T cells consisted of clonal T cell populations 
(  Fig. 3  ).   The clonality of the PLA-specifi  c T cells increased in 
the IL-10  –  secreting population 7 d after the onset of bee-
keeping season but decreased (primer set B) or dis  appeared 
(primer set D) in the IFN-      –  secreting T cells. Interestingly, 
the clone detected by primer set D disappeared from the 
IFN-      –  secreting population after the onset of the beekeeping 
season and appeared in the IL-10  –  secreting population. 
  To further support an in vivo switch to Tr1 cells, we de-
termined the frequency of TCRV     chains among purifi  ed 
PLA-specifi  c IL-4  –  , IL-10  –  , and IFN-      –  secreting T cells that 
were expanded in vitro with IL-2 and irradiated autologous 
PBMCs (  Fig. 4 A  ).   7 d after the onset of beekeeping season, 
TCRV    2-positive T cells from beekeeper A switched from 
a predominantly IL-4  –  secreting profi  le to a predominantly 
IL-10  –  secreting profi  le (Table S1, available at http://www
.jem.org/cgi/content/full/jem.20080193/DC1). In addition, 
TCRV    12-positive T cells switched from a predominantly 
IFN-      –   and IL-4  –  secreting profi  le to an IL-10  –  secreting pro-
fi  le. In beekeeper B, an increase in IL-10 –  producing TCRV    8- 
and TCRV    20-positive T cells occurred after the onset of 
bee stings, whereas cells producing IFN-     and IL-4 decreased 
in these populations (Table S1). We then purifi  ed cytokine-
secreting CD4  +   T cell populations before and after the onset 
of bee stings and determined the frequency of TCRV    -ex-
pressing CD4  +   T cells among these populations (  Fig. 4 B  ). 
Table S2 shows the overall numbers of cytokine-producing 
cells (per 10,000 CD4  +   T cells) before and after the onset of 
beekeeping season in beekeepers A and B. When the expres-
sion of   TCRV     genes was assessed in these populations, a strik-
ing shift toward IL-10 secretion was seen among   TCRV    2- and 
V    12-expressing cells in beekeeper A (  Fig. 4, A and B  ). In the 
V    2- and V    12-expressing populations, IL-10  –  secreting cells 
expanded from 0.2 to 2.9 and from 0.1 to 1.8 T cells per 
10,000 CD4  +   T cells, respectively. In beekeeper B, IL-10  –
  secreting cells among the TCRV    8- and V    20-positive popu-
lations expanded from 0.1 to 4.3 and 0.05 to 0.8 T cells per 
10,000 CD4  +   T cells, respectively. Collectively, these data sug-
gest that continued exposure to bee venom allergen induces 
an in vivo expansion of IL-10  –  producing, allergen-specifi  c 
    Figure 2.         Increased allergen-specifi  c Tr1 cells and decreased Th1 
and Th2 cells after bee stings.   (A)  PLA-specifi   c  IL-4 – ,  IL-10 – ,  and  IFN-
    – secreting  CD4 +   T cells were purifi  ed 12 h after PLA stimulation, and 
their frequencies were calculated in six beekeepers before the beginning 
of beekeeping season and after 7 d. They received an average of 13 bee 
stings. Data are expressed as means + SEM. (B) Frequency of PLA-stim-
ulated cytokine-secreting cells in six beekeepers by ELISPOT assay. 
(C) Secreted cytokines in PLA-stimulated PBMC cultures were measured by 
ELISA (IL-4 after 24 h, and IL-13, IFN-    , and IL-10 after 5 d). (D) PBMCs 
from beekeepers were stimulated with PLA for 10 d, and intracytoplas-
mic cytokines were determined 12 h after anti-CD2/-CD3/-CD28 mAb 
stimulation. The mean percent difference (standard deviations are in 
parentheses) of eight experiments is shown before and 7 d after mul-
tiple bee stings inside each histogram. (E) PLA-specifi   c  IL-4 – ,  IL-10 – , 
and IFN-      –  secreting and Der p 1  –   and Bet v 1  –  specifi   c  IL-10 – secreting 
T cells were purifi  ed from beekeepers after multiple bee stings. Their 
frequency was calculated in CD4  +   T cells, and PBMCs were immediately 
reconstituted by increasing their frequency in cultures by 10 times. 
Cells were stimulated with PLA, and [  3  H]thymidine incorporation was 
determined after 5 d. Three experiments are shown. Data are expressed 
as means + SEM. *, P   <   0.001. i.c., intracutaneous.     
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other mechanisms also appeared to function in immune tol-
erance to high dose venom allergens, as the neutralization 
of either CTL-associated antigen (CTLA)-4 or programmed 
death (PD) 1 signifi  cantly reversed suppression of PLA-spe-
cifi  c T cell proliferation (  Fig. 7 B  ). As noted earlier, PLA-in-
duced T cell proliferation was signifi  cantly higher in PBMCs 
from beekeepers before being stung (  Fig. 7 B  , column 2), and 
suppression of proliferation could be achieved by increas-
ing the frequency of PLA-specifi  c IL-10  –  secreting T cells by 
10-fold (  Fig. 7 B  , column 3). This suppressive eff  ect was par-
tially inhibited by blocking CTLA-4, PD-1, or IL-10R (  Fig. 
7 B  , columns 4  –  9). Blocking two of the receptors simultane-
ously also partially inhibited the suppressive eff  ect of IL-10  –
  secreting T cells (  Fig. 7 B  , columns 12  –  14). Blocking all three 
receptors simultaneously had an additive eff  ect in reconstitu-
tion of suppressed allergen-specifi  c T cell proliferation (  Fig. 7 B  , 
column 15). 
CD4  +   T cells at the expense of IFN-      –  producing (Th1) and 
IL-4  –  producing (Th2) cells. 
  Role of HR2 in peripheral T cell tolerance 
  Exposure to bee venom induces the degranulation of mast 
cells and basophils (below the threshold of systemic anaphy-
laxis), and histamine is one of the major mediators of degran-
ulation (  20  ). Functional HRs are expressed on T cells, but so 
far their role in regulating immune responses after allergen 
exposure in humans has not been studied in detail. The ex-
pression of HR2 mRNA on allergen-specifi  c T cells increased 
signifi  cantly 7 d after the onset of beekeeping season (  Fig. 
5 A  ).   However, there was no change in mRNA levels of HR1, 
HR4, or FoxP3 in control cells stimulated with PHA or 
PPD. After bee stings, HR2 expression was increased exclu-
sively on IL-4  –  secreting T cells and did not change on IFN-      –   
or IL-10  –  secreting T cells (  Fig. 5 B  ). The expression of FoxP3 
was relatively low in allergen-stimulated cells compared with 
purifi  ed CD4  +  CD25  +   cells and did not change in either 
  population after the onset of beekeeping season. There was 
also no change in the overall percentage of CD4  +  CD25  +   
T cells in response to bee stings (unpublished data). Next, we 
investigated whether the increased expression of HR2 on IL-
4  –  producing Th2 cells aff  ects their subsequent production of 
IL-10 in response to histamine. PLA-specifi  c IL-4  –  secreting 
T cells were purifi  ed and stimulated with increasing doses of 
histamine in the presence or absence of the HR2 antagonist 
ranitidine. Histamine treatment decreased the production of 
IL-4 and IL-13 and increased the production of IL-10 pro-
duction in a dose-dependent fashion (  Fig. 5 C  ). This eff  ect 
depended on HR2 expression, as it was completely reversed 
by ranitidine (  Fig. 5 C  ). 
  The relative roles of HR2 and IL-10 in allergen-specifi  c T 
cell unresponsiveness was investigated by measuring the prolif-
eration of PBMCs in response to PLA in the presence of raniti-
dine or an anti  –  IL-10R blocking mAb. Before the onset of 
beekeeping season, PLA stimulation induced proliferation in 
3.22   ±   0.71% of CD3  +  CD4  +   T cells, and IL-10 suppressed this 
proliferation to background levels. In PBMCs taken 7 d after 
the onset of beekeeping season, proliferating CD3  +  CD4  +   T 
cells signifi  cantly decreased to 0.86   ±   0.41% of CD3  +  CD4  +   
cells but were rescued by blocking the IL-10R or HR2. Block-
ing both receptors had an additive eff  ect (  Fig. 6, A and B  ).   
  Predominant role of IL-10 but not TGF-     
in skin-related tolerance 
  Multiple suppressive mechanisms play a role in suppression of 
allergen-specifi  c Th2 cells. IL-10 and TGF-     have been sug-
gested to cooperate in suppression of mucosal allergen-specifi  c 
T cell activation (  12  ). In our system, IL-10 appeared to play 
a more dominant role than TGF-     in suppression of PLA-
specifi  c T cell responses, as blocking the IL-10R, but not the 
TGF-     receptor, reconstituted T cell proliferation and cyto-
kine production in PBMCs isolated after the onset of beekeep-
ing season (  Fig. 7 A  ).   The suppressive eff  ect of IL-10 on the 
expression of both IFN-     and IL-13 was comparable. Two 
    Figure 3.         Clonality and switch to IL-10  –  secreting T cells after bee 
stings.   TCRV    gene clonality was analyzed in PLA-specifi   c  IL-4 – ,  IL-10 – , 
and IFN-      –  secreting T cells before and 7 d after multiple bee stings. A 
clonal sample (C) and a nonclonal sample (N) were included as controls. The 
PCR products of three different test tubes were run on three different gels, 
and a band that results from a clonal sample appears in a range from 240 
to 285 bp (primers A, tube 1), from 240 to 285 bp (primers B, tube 2), and 
from 285 to 325 bp and from 170 to 210 bp (primers C and D, tube 3). The 
specimen control size ladder master mix generates a series of amplicons to 
ensure that the quality and quantity of input DNA were suffi  cient for the 
test. Heteroduplex analysis of the PCR products (except for the specimen 
control size ladder) on 6% TBE polyacrylamide gels stained with ethidium 
bromide is shown. One representative out of three experiments is shown.     2892 T REGULATORY 1 CELLS IN HIGH DOSE ALLERGEN TOLERANCE   | Meiler et al. 
cifi  c T cells from Th1 and Th2 cells toward IL-10  –  secreting 
Tr1 cells occurs within a few days. These sequential events 
are repeated every year. At the end of every season when 
there is no exposure, the peripheral T cell response returns to 
the same levels as seen before exposure within 2 to 3 mo. 
The changes in cytokine profi  le, T cell proliferation, and cu-
taneous late-phase response show parallel changes, demon-
strating that the T cell tolerance induced by an in vivo switch 
to Tr1-like IL-10  –  secreting cells is short lived and dependent 
on antigen exposure. There is so far no report on in vivo 
turnover and life span of Tr1 cells in humans, but our data 
    DISCUSSION   
  The immune system must distinguish between innocuous 
and pathological antigens to prevent unnecessary and self-de-
structive immune responses (  22, 23  ). The present study fo-
cuses on how soluble protein antigens encountered via skin 
exposure are tolerated. Key fi  ndings of the present study con-
cern the time-span and allergen-dependence of allergen-spe-
cifi  c peripheral T cell tolerance. The cytokine profi  le of 
memory T cells specifi  c for PLA show an IL-10  –   and IFN-
      –  predominant profi  le outside of beekeeping season. Upon 
bee venom exposure, an immediate switch of allergen-spe-
    Figure 4.         PLA-specifi  c CD4  +   IL-4  –   and IFN-      –  secreting CD4  +   T cells switch to IL-10  –  secreting T cells.   (A) Two beekeepers were analyzed for 
TCRV     chain expression in purifi  ed PLA-specifi  c IL-4  –  , IL-10  –  , and IFN-      –  secreting T cells by gating CD3  + CD4 +   T cells by fl  ow cytometry. (B) PLA-specifi  c 
IL-10 – ,  IFN-     –  , and IL-4  –  secreting T cells were purifi  ed from two beekeepers before and 7 d after multiple bee stings. They were stimulated either with 
PLA (beekeeper A V    2) or anti-CD3 mAb (all of the other panels) in the presence of irradiated autologous PBMCs and were expanded with IL-2 for 12 d. 
The entire panel of TCR mAbs was used for staining. A signifi  cant switch in TCRV    2 and 12% (beekeeper A) and TCRV    8 and 20% (beekeeper B) of posi-
tive cells between T cell subsets after bee stings is shown. A change in TCRV   -expressing  CD4 +   T cell frequency is accepted as signifi  cant if an increase in 
the frequency of IL-10  –  secreting T cells is observed together with a decrease in either IFN-      –   or IL-4  –  secreting T cells that is two times bigger than the 
average of four healthy controls. (B) The changes in the frequency of TCRV   -expressing  CD4 +   T cells was calculated by multiplying the percentage of 
TCRV     with the frequency of the same cytokine-secreting PLA-specifi  c CD4  +   T cell subset.     JEM VOL. 205, November 24, 2008 
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CD4  +   T cells in the presence of IL-10 in vitro (  32  ). The 
nonspecifi  c T cell suppressor activity of IL-10 and TGF-     
has been consistently reported in experiments with high 
amounts of exogenously added suppressor cytokines (  18  ). 
are consistent with the life span of conventional T reg cells 
analyzed by Vukmanovic-Stejic et al., which showed that 
the in vivo doubling time of FoxP3  +  CD25  hi  CD4  +   T cells 
was relatively short (8 d) in resting conditions compared with 
FoxP3       CD25       CD4  +   T cells (24 d) (  24  ). Interestingly, when 
bee venom contact ceased, the Tr1 response substantially de-
creased within 2 mo after the end of the season. 
  Another essential fi  nding of the present study demon-
strates in vivo switch in allergen-specifi  c IL-4  –   and IFN-      –
  producing T cells toward IL-10  –  producing T cells. The 
consistent profi  le of PLA-specifi  c T cell proliferation in bee-
keepers throughout consecutive years demonstrates a bipha-
sic T cell response with substantial peripheral T cell tolerance 
upon high dose allergen exposure. The long-term PLA-spe-
cifi  c T cell repertoire has been maintained in a balance of 
42% IFN-      –  secreting T cells, 43% IL-10  –  secreting T cells, 
and 15% IL-4 secreting T cells. Immediately after bee stings, 
the repertoire changed and consisted of 80% IL-10  –  secreting 
T cells, 14% IFN-      –  secreting T cells, and 6% IL-4  –  secreting 
T cells. The stability of cytokine profi  les in diff  erentiated 
  eff  ector and memory T cell subsets in humans is not fully 
known, and it has been demonstrated that lineage-commit-
ted memory T cell subsets are responsive to cytokine signals 
from the opposing lineage (  25, 26  ). The frequency of single 
PLA-specifi  c CD4  +   Tr1 cells ranges between 1 in 1,000 and 
1 in 20,000 of the whole CD4  +  CD25  +   T reg pool. The T 
cell epitope restriction pattern of PLA varies considerably 
from patient to patient, and at least four epitopes have been 
demonstrated (  27, 28  ). In the present study, PLA-specifi  c T 
cells demonstrated a clonality throughout the whole season. 
In both experiments, which investigated their TCR clonality 
by PCR and fl  ow cytometry, an immediate switch to IL-10  –
  producing Tr1 cells was observed in vivo after bee stings. 
Similarly, IL-10  –  secreting allergen-specifi  c T cells represented 
the predominant subset and were present at a signifi  cantly 
higher frequency than IL-4  –   and IFN-      –  secreting T cells in 
food- and aeroallergen-sensitized individuals who did not 
develop an allergic response (  12  ). Our data suggest that other 
mechanisms may be operative in addition to switch from one 
T cell subset to the other. For example, the percentage of IL-
10  –  secreting T cells decreased in beekeeper B in V    2 and 
V    3-expressing T cells. The percentage of both IL-4  –   and IL-
10  –  secreting cells increased in beekeeper A in TCRV    5.1- and 
-12-positive T cells. One explanation for this is that the cyto-
kine profi  le of these purifi  ed subsets consisted of some Th0 
cells, which secrete both Th1 and Th2 cytokines as well as 
IL-10 and TGF-    . Further studies are needed to determine 
whether activation-induced cell death and deletion of T cells 
takes place in vivo. 
  Allergen-SIT in humans has been used successfully to 
treat allergies by inducing responsive cells to secrete IL-10, and 
this is analogous to the studies of low-zone tolerance (  29  ). 
The IL-10  –  producing CD4  +   Tr1-cell population is induced 
by T cell epitope peptide immunotherapy and whole allergen 
SIT (  12, 17, 18, 21, 30, 31  ). Tr1 cells specifi  c for a variety 
of antigens arise in vivo but may also diff  erentiate from naive 
    Figure 5.         HR2 is up-regulated in specifi  c T cells after multiple bee 
stings and induces IL-10 production.   (A) PBMCs were stimulated with 
PLA for 5 d. HR1, HR2, HR4, and FoxP3 mRNAs were determined 4 h after 
anti-CD3/-CD28 mAb stimulation before and 7 d after multiple bee stings. 
For comparison, PPD- and PHA-stimulated cells did not show any differ-
ence. (B) HR2 and FoxP3 were analyzed in purifi  ed allergen-specifi  c IL-4  –  , 
IL-10 – ,  and  IFN-     –  secreting T cells immediately after purifi  cation and in 
CD4  + CD25 +   and  CD4 + CD25       T cells. (C) PLA-specifi  c IL-4  –  secreting T cells 
were purifi  ed, expanded for 12 d, and stimulated with different doses of 
histamine in the presence or absence of 10     4   M ranitidine. Cytokines were 
determined by ELISA 3 d after anti-CD2/-CD3/-CD28 mAb stimulation. 
Data are expressed as means + SEM.     2894 T REGULATORY 1 CELLS IN HIGH DOSE ALLERGEN TOLERANCE   | Meiler et al. 
  The present study demonstrates that HR2 represents an 
essential receptor that participates in peripheral tolerance to 
allergens by the induction of IL-10 and direct suppression of 
the proliferation of allergen-specifi  c T cells. HR2 is a potent 
suppressor of several infl  ammatory and eff  ector functions. 
Histamine induces the production of IL-10 by dendritic cells 
(  35  ) and enhances the suppressive activity of TGF-     on T 
cells via HR2 (  36  ). In the diff  erentiation process of mono-
cyte-derived dendritic cells, HR2 acts as a suppressive mol-
ecule for antigen-presentation capacity, suppresses IL-12 
production, and enhances IL-10 production (  35, 37  ). All of 
these immune tolerance  –  promoting eff  ects are mediated via 
HR2, which is relatively highly expressed on Th2 cells and 
suppresses IL-4 and IL-13 production as well as T cell pro-
liferation (  15  ). 
However, the present study demonstrates that Tr1 cells dis-
play antigen-specifi  c suppressor activity in very low numbers. 
It can be hypothesized that depending on their frequency, 
the fi  rst T cell that contacts the APC may be very decisive for 
inducing or suppressing the generation of a specifi  c im-
mune response. Accordingly, if the fi  rst T cell to contact 
the APC is a Tr1 cell, it may silence or down-regulate the 
maturation of the APC. IL-10 down-regulates antigen-pre-
senting capacity such as HLA-DR expression, co-stimulatory 
molecules, and several cytokines in dendritic cells and mono-
cytes/macrophages (  33  ). Diff  erentiation of a distinct dendritic 
cell subset in the presence of IL-10 has been demonstrated, 
which induces tolerance through the generation of Tr1 
cells (  34  ). 
    Figure 7.         Multiple suppressive mechanisms play a role in peripheral 
allergen tolerance.   (A) Endogenous IL-10, TGF-    , or both were neutralized 
in PLA-stimulated PBMCs of beekeepers during beekeeping season. 
[  3  H]Thymidine incorporation (TdR), IFN-    , and IL-13 were determined at day 
5. (B) PLA-specifi  c proliferation of PBMCs from beekeepers before multiple 
bee stings is suppressed by a 10 times  –  increased frequency of PLA-specifi  c 
IL-10  –  secreting T cells. The activity of IL-10R, CTLA-4, and PD-1 was neutral-
ized. [  3  H]Thymidine incorporation was determined at day 6. The same results 
were obtained in six independent experiments in A and three independent 
experiments in B, all performed with freshly purifi  ed cells without in vitro 
expansion. Data are expressed as means + SEM. IC, isotype control antibody.    
    Figure 6.         HR2 and IL-10 play major roles in peripheral T cell toler-
ance to high dose antigen exposure.   (A) PBMCs of beekeepers were la-
beled with CFSE, and dilutions in CFSE-expressing cells were analyzed in the 
presence of IL-10, anti  –  IL-10R mAb (blocking), and 10     4   M ranitidine before 
and 7 d after multiple bee stings. BSA, TT, and bee venom allergen hyal-
uronidase were used as control antigens in beekeepers who did not show 
signifi  cant proliferation to these antigens. On day 6, cells were collected, 
stained with anti-CD4 PE and anti-CD3 PE Texas red and analyzed by fl  ow 
cytometry (means   ±   standard deviation of percentages of dividing cells are 
shown in one representative out of three beekeepers). us, unstimulated. 
(B) PBMCs of three different beekeepers were stimulated with PLA and dif-
ferent doses of ranitidine or anti  –  IL-10R mAb or both. [  3 H]Thymidine  incor-
poration was determined on day 6. Data are expressed as means + SEM.     JEM VOL. 205, November 24, 2008 
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essential roles in immune response and sensitization (  23  ). The 
doses of venom allergens received during natural bee stings in 
the bee venom model can be estimated. The average of 13 bee 
stings corresponds to a high dose of allergen exposure, con-
sisting of at least 65   μ  g of PLA inoculated intracutaneously. It 
is commonly known that a single Hymenoptera sting is suffi   -
cient to induce allergic sensitization. It is related to the num-
ber of stings and the short interval between the two stings 
(  44  ). In the fi  rst month after a bee sting,   >  30% of adults show 
allergic sensitization. Skin tests become negative in 30% of 
patients after 2 yr and in virtually 50% after 3 yr (  44  ). For in-
door and outdoor allergens, the total amount of exposure is 
essentially impossible to quantify, but the risk for natural sen-
sitization in nonatopic individuals, except for occupational 
exposure such as in lawn cutters, is very low (  45  ). 
  Studies on T cell response to allergens in healthy individu-
als have demonstrated a wide range of immune response, from 
no detectable response to involvement of active peripheral 
tolerance mechanisms (  17  ). In a high number of healthy indi-
viduals, T cells do not show any proliferative response to aller-
gens in PBMC cultures. This can be caused by a low frequency 
of specifi  c T cells caused by lack of exposure or exposure be-
low the threshold of a sensitizing dose. Active suppression 
against allergens by T reg cells occurs in sensitized healthy in-
dividuals (  12, 46  ). In individuals, who show a detectable IgG4 
response, a balanced allergen-specifi  c immune response caused 
by the expansion of Tr1 cells has been demonstrated (  12  ). Al-
though all of the beekeepers included in the present study had 
detectable IgE against PLA, they showed extremely high spe-
cifi  c IgG4, which could be one of the reasons for the preven-
tion of severe anaphylaxis. Their serum-specifi  c IgE was in the 
range of allergic individuals, but specifi  c IgG4 was a few hun-
dred times higher than allergic individuals (  47  ). Collectively, 
our results indicate that the control of Th2 and Th1 immune 
responses against naturally exposed harmless environmental 
antigens is mediated by Tr1 cells in humans. Eff  ector (allergen-
specifi  c Th2) and suppressor (allergen-specifi  c Tr1) T cells ex-
ist in both healthy and allergic individuals in certain amounts. 
Their ratio determines the development of a healthy or an 
  allergic immune response. These data may explain the sponta-
neous development and spontaneous remission of allergic 
diseases. In addition to allergy, these mechanisms may have 
implications in autoimmunity, graft-versus-host disease, tumor 
cell growth, parasite survival and chronic infections. 
  MATERIALS AND METHODS 
  Study population and allergens.     10 beekeeper volunteers (mean age = 
58 yr, range = 34  –  71 yr; 9 male and 1 female; average beekeeping time = 36 yr, 
range = 17  –  46 yr) who reported that they do not use protective equipment 
and show cutaneous late-phase swelling response to bee stings in the begin-
ning of each season were studied. Five beekeepers were followed for 3 yr 
between 2003 and 2005. Physical examination was performed after 24 h, and 
the diameters of skin late-phase lesions were measured (  21, 42, 43  ). Lesion 
size was graded as follows: 2,   >  3 cm; 1, 0  –  3 cm; and 0, no swelling. All of 
the beekeepers had detectable IgE against bee venom PLA (mean = 7.55   ±   
1.63 RU/ml), and they showed extremely high IgG4 (2,493   ±   418 ng/ml). 
Four healthy individuals (mean age = 43 yr, range = 34  –  47 yr; two male 
and two female) were used as controls. The study was approved by the ethical 
  Allergen-specifi  c T cell tolerance uses multiple suppressor 
mechanisms. The roles of CTLA-4 and PD-1 are demon-
strated in the present study, in addition to IL-10R and HR2. 
CD4  +  CD25  +   T cells are the only lymphocyte subpopulation 
in both mice and humans that expresses CTLA-4 constitu-
tively. Its expression apparently correlates with the suppressor 
function of CTLA-4 (  38  ). As demonstrated in the present 
study for Tr1 cells, the blocking of CTLA-4 activity has been 
shown to reverse the suppression in co-cultures of CD4  +  CD25  +   
and CD4  +  CD25        T cells (  38  ). Similarly, the treatment of 
mice, which are recipients of CD4  +  CD45RB  low   T cells with 
CTLA-4-blocking agents, abrogated the suppression of in-
fl  ammatory bowel disease (  39  ). These studies indicate that the 
engagement of CTLA-4 on the CD4  +  CD25  +   T cells by anti-
body or by CD80/CD86 might lead to inhibition of the 
TCR-derived signals that are required for the induction of 
suppressor activity. PD-1 is an immunoreceptor tyrosine-based 
inhibitory motif  –  containing receptor expressed upon T cell 
activation. PD-1  –  defi  cient mice develop autoimmune diseases, 
suggesting an inhibitory role for PD-1 in immune responses 
(  40  ). Members of the B7 family, PD-ligand (L) 1 and PD-L2, 
are ligands for PD-1. PD-1/PD-L engagement on mouse CD4 
and CD8 T cells results in inhibition of proliferation and cyto-
kine production. T cells stimulated with anti-CD3/PD-L1Fc  –
  coated beads display dramatically decreased proliferation and 
IL-2 production (  41  ). 
  This model represents a high dose of allergen inoculation 
via skin. Induction of clinical tolerance parallel to immuno-
logical tolerance should be emphasized here, because these 
beekeepers showed local cutaneous late-phase reactions char-
acterized by local swelling during the fi  rst few bee stings of 
every new season, which signifi  cantly decreased after 1 wk. 
There is no detailed report on the characterization of cellular 
infi  ltration in natural bee venom  –  induced cutaneous late-phase 
response. Biopsies of skin late-phase responses were investi-
gated in several studies with other allergens. It was demon-
strated that CD3  +   T cell infi  ltration starts at 6 h, peaks at 24 h, 
and declines after 48 h. CD3  +  CD45RO  +   T cells, eosinophils, 
and macrophages dominate the lesions without neutrophils 
(  42, 43  ). The kinetics and the type of infi  ltrating cells in aller-
gen-induced skin late-phase lesions are clearly diff  erent com-
pared with delayed-type hypersensitivity lesions, which peak 
at 72 h, and are characterized with infi  ltrating T cells and mac-
rophages, without eosinophils (  24  ). A signifi  cant decrease in 
skin late-phase lesion size and T lymphocyte and eosinophil 
infi  ltration has been demonstrated in allergen-SITs performed 
by the injection of allergen extracts via conventional allergen-
SIT and T cell epitope peptide-SIT (  21, 30, 31  ). 
  Immune response during the fi  rst confrontation of the al-
lergens with the immune system depends on multiple factors. 
Biochemical properties of the allergen; other innate immune 
response stimulating substances in the milieu of the allergen at 
the time of exposure (within the same extract or coexposure 
with an infection or a vaccine); stability of the allergen in the 
tissues, digestive system, skin, or mucosa; and, fi  nally, dose 
and time during the interaction with the immune system play 2896 T REGULATORY 1 CELLS IN HIGH DOSE ALLERGEN TOLERANCE   | Meiler et al. 
  Biotechnology Limited). CTLA-4 activity was neutralized with 5   μ  g/ml 
anti  –  CD152 F(ab    )  2   (Ancell; Enzo Biochem, Inc.). The neutralizing activity 
of all of these approaches was demonstrated in titrated doses. Rabbit IgG, rat 
IgG, mouse IgG1, or BSA (Beckman Coulter) served as controls. 
  Flow cytometry, ELISA, and ELISPOT.     PBMCs of beekeepers before 
and 7 d after they received multiple bee stings were stimulated with PLA for 
10 d. Intracellular cytokines were detected after 12 h of anti-CD2, -CD3, 
and -CD28 mAb stimulation. 2   μ  M monensin (Sigma-Aldrich) was added 
during the last 10 h (  11  ). The solid-phase sandwich ELISAs for IFN-    , IL-4, 
IL-10, and IL-13 were performed in supernatants obtained at day 5 (  11  ). 
  10  6   PBMCs/ml from six healthy donors were stimulated in 200   μ  l of 
medium in 96-well fl  at-bottom ELISPOT plates for 18 h (Euroclone Ltd.). 
Locally produced IL-4, IFN-    , and IL-10 were captured by specifi  c mAbs. 
After cell lysis, trapped cytokine molecules were revealed by a secondary bio-
tinylated detection antibody, which is recognized by streptavidin conjugated 
to alkaline phosphatase. Colored (purple) spots developed after substrate 
  addition were determined (ImmunoSpot; Cellular Technology Ltd.). The 
number of spots determined in triplicates of unstimulated wells was subtracted 
from 0.3   μ  M PLA  –  stimulated wells. 18 h was found to be the optimal time 
for the determination of frequency of cytokine-secreting cells, as it is the time 
point for the highest cytokine secretion before T cell proliferation starts. 
  Quantitative real-time PCR.     Immediately after purifi  cation, antigen-
  specifi  c cytokine-secreting T cells were lysed with RNeasy lysis buff  er, and 
the RNA was isolated using the RNeasy mini kit (QIAGEN) and eluted 
in 30   μ  l ddH  2  O. RT was performed with TaqMan RT reagents with ran-
dom hexamers (Applied Biosystems). The PCR primers and probes were 
designed based on sequences available from GenBank/EMBL/DDBJ un-
der the following accession nos.: EF1,   NM_001402  ; IL-13,   NM_002188  ; 
IFN-    ,   NM_000619  ; IL-10,   NM_000572  ; TGF-    1,   NM_000660  ; HR1, 
  NM_001098213  ; HR2,   NM_001131055  ; HR4,   NM_021624  ; and Foxp3, 
  NM_014009  . Primers were as follows: EF-1     forward, 5    -CTGAACCATC-
CAGGCCAAAT-3    ; EF-1     reverse, 5    -GCCGTGTGGCAATCCAAT-3    ; 
IL-13 forward A, 5    -GCCCTGGAATCCCTGATCA-3    ; IL-13 reverse A, 
5    -GCTCAGCATCCTCTGGGTCTT-3    ; IFN-     forward B, 5    -TCTC-
GGAAACGATGAAATATACAAGTTAT-3    ; IFN-     reverse B, 5    -GTA-
ACAGCCAAGAGAACCCAAAA-3    ; IL-10 forward, 5    -GGCGC  TGT-
CATCGATTTCTT-3    ; IL-10 reverse, 5    -TTGGAGCTTATTAAA  GG-
CATTCTTC-3    ; TGF-    1 forward, 5    -AAATTGAGGGCTTTCGCC-
TTA-3    ; TGF-    1 reverse, 5    -GAACCCGTTGATGTCCACTTG-3    ; HR1 
forward, 5   -TCTCGAACGGACTCAGATACCA-3    ; HR1 reverse, 5   -CCT-
GTGTTAGACCCACTCCTCAA-3    ; HR1 probe, FAM-ACAGAGACA-
GCACCAGGCAAAGGCAA-TAMRA; HR2 forward, 5    -GCTGGGC-
TATGCCAACTCA-3    ; HR2 reverse, 5    -GGTGCGGAAGTCTCTGTT-
CAG-3    ; HR2 probe, FAM-CCCTGAACCCCATCCTGTATGCTGC-
TAMRA; HR4 forward, 5    -GGGTCTTGAAGATTGTTACTCTGATG-3    ; 
HR4 reverse, 5    -CTAGAATCATTGGCCCATTCACT-3    ; HR4 probe, 
FAM-GCCAGCACCCAAACGGCCA-TAMRA; Foxp3 forward, 5    -CCC-
GGCCTTCCACAGAA-3    ; and Foxp3 reverse, 5    -CACCCGCACAAA-
GCACTTG-3     (all were from obtained from Microsynth AG). cDNAs were 
amplifi  ed using SYBR-PCR Master Mix (Applied Biosystems) according to 
the recommendations of the manufacturer in a total volume of 25   μ  l in an 
ABI PRISM 7000 Sequence Detection System (Applied Biosystems). Rela-
tive quantifi  cation was performed as previously described (  52  ). All amplifi  ca-
tions were performed in duplicates. 
  TCRV     chain detection on CD4  +   T cells.     PLA-specifi  c IL-10  –  , IFN-
      –  , and IL-4  –  secreting T cells were purifi  ed from beekeepers before and 7 d 
after multiple bee stings. They were stimulated either with PLA or anti-CD3 
mAb (beekeeper A) in the presence of 3,000 rads of irradiated autologous 
PBMCs and expanded with 25 U/ml IL-2 (Proleukin; Novartis) for 12 d. 
Anti-CD3 stimulation was used in beekeeper A, because IFN-      –  secreting T 
cells did not expand with PLA stimulation. PBMCs of four healthy donors 
were used for controls. Cells were blocked for 10 min at room temperature 
commission of the Canton of Grissons, Switzerland. Recombinant PLA of 
honey bee venom (  Apis mellifera  ) was produced in house (  48  ). Hyaluronidase 
of bee venom (a gift from U. M  ü  ller, Spital Bern, Bern, Switzerland), rBet 
v 1 of birch pollen (  Betula verrucosa  ), rDer p 1 of house dust mites (  Dermatopha-
goides pteronyssinus  ; both from Allergopharma Joachim Ganzer KG), PPD of 
  Mycobacterium bovis  , and TT (both from Serum Institute) were used as control 
antigens. None of the allergens contained detectable amounts of LPS and all 
were   >  99% pure. 
  Purifi  cation of allergen-specifi  c IL-4  –  , IFN-      –  , and IL-10  –  secreting 
cells.     PBMCs were isolated by Ficoll (Biochrom) density gradient centrifu-
gation of peripheral venous blood, and cells were washed three times and re-
suspended in RPMI 1640 medium supplemented as previously described 
(  12  ). 2.5   ×   10  7   cells were stimulated with 0.3   μ  M of antigens in 5 ml of me-
dium in 6-well plates in duplicates (Costar Corp.). After 12 h of stimulation 
in humidifi  ed 5% CO  2  , cells were harvested and labeled with 50   μ  g/ml anti  –
  IFN-    /CD45, anti  –  IL-4/CD45, or anti  –  IL-10/CD45 antibody-antibody 
conjugates (Miltenyi Biotec) for 10 min at a concentration of 10  8   cells/ml in 
ice-cold RPMI 1640 medium (  49  ). The cells were diluted with 37  °  C warm 
medium to a fi  nal concentration of 10  6   cells/ml and were allowed to secrete 
and capture the respective cytokines for 45 min at 37  °  C. After capturing the 
secreted cytokines on their surface, cells were centrifuged at 300   g   for 5 min 
at 4  °  C and resuspended at a concentration of 10  8   cells/ml in ice-cold buff  er 
containing 0.5% BSA and 5 mM EDTA (both from Sigma-Aldrich) in PBS. 
The cells were then stained with 5   μ  g/ml PE-conjugated anti  –  IFN-    , anti  –
  IL-10, or anti  –  IL-4 for 10 min at 4  °  C. The cells were washed and resus-
pended in BSA-EDTA PBS (10  8   cells/ml) and magnetically labeled for 
15 min at 4  °  C with 20   μ  l/10  7   cells of anti-PE microbeads (Miltenyi Biotec). 
After washing, labeled cells were purifi  ed by immunomagnetic separation 
(AutoMacs; Miltenyi Biotec). The cells were counterstained by FITC-la-
beled anti-CD4 mAb (Beckman Coulter) and were analyzed in a fl  ow cy-
tometer (Epics XL; Beckman Coulter), and their percentage in whole CD4  +   
T cells and frequency were calculated. Together with the quantitative cyto-
kine mRNA and secreted cytokine profi  les, these data demonstrate that 
  antigen-specifi  c Tr1, Th1, and Th2 cells can be purifi  ed from human pe-
ripheral blood (Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20080193/DC1), and they are specifi  c for the allergen that they are ini-
tially stimulated for in the purifi  cation (Fig. S3). The purity of allergen-spe-
cifi  c CD4  +   cytokine-secreting cells was between 88 and 96%. The frequency 
of allergen-stimulated and unstimulated cells was calculated by dividing the 
number of purifi  ed cytokine-secreting CD4  +   T cells by the initial number of 
CD4  +   T cells (Supplemental materials and methods). 
  T cell cultures.     Allergen-specifi  c T cell proliferative response was deter-
mined by stimulation of 2   ×   10  5   PBMCs alone or together with freshly puri-
fi  ed allergen-specifi  c cytokine-secreting T cells for 5 d with 0.3   μ  M of 
allergens, and 1   μ  g/ml TT and PPD in 200   μ  l of medium in 96-well fl  at-bot-
tom tissue culture plates in triplicates (  50  ). Cells were pulsed with 1 mCi/
well [  3  H]thymidine (DuPont; New England Nuclear), and the incorporation 
of labeled nucleotide was determined after 8 h in an LKB      plate reader (GE 
Healthcare). PBMCs were stimulated for 5 d with 1   μ  g/ml PLA, PPD, or 
PHA, PHA (Sigma-Aldrich). HR1, HR2, HR4, and FoxP3 mRNAs were 
determined 4 h after 0.5   μ  g/ml anti-CD2, -CD3, and -CD28 mAb (CLB) 
stimulation before and 7 d after multiple bee stings. Cell proliferation was 
additionally measured by CFSE labeling. Cells were labeled with 5   μ  M 
CFSE (Invitrogen) and washed twice with medium before being subjected 
to the PLA stimulation. After 5 d, CD4  +   cells were counterstained with 
PC5-labeled anti-CD4 and PE Texas red  –  labeled anti-CD3 mAbs (BD) and 
analyzed by fl  ow cytometry. 
  Allergen-specifi  c cytokine-secreting T cells were used immediately after 
purifi  cation in all experiments. IL-10 was neutralized in cultures with 4   μ  g/ml 
anti  –  IL-10R mAb (DNAX Research Institute) (  51  ). TGF-     was neutralized 
in cultures with 100 ng/ml of recombinant human soluble TGF-     receptor 
II/Fc chimeric protein (R  &  D Systems) (  18  ). PD-1 activity was neutral-
ized in cultures with 5   μ  g/ml anti  –  human PD-1 (Bioscience Insight JEM VOL. 205, November 24, 2008 
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